Patents by Inventor Meghan C. Campbell

Meghan C. Campbell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A2A ANTAGONISTS AS COGNITION AND MOTOR FUNCTION ENHANCERS
    Publication number: 20220125772
    Abstract: Methods are described for inducing cognition and motor function enhancement in patients suffering from Parkinson's disease by administering an effective amount of an Adenosine 2a antagonist. The Adenosine 2a antagonist can optionally be administered in combination with a dopamine precursor, such as levodopa, or a dopamine receptor agonist.
    Type: Application
    Filed: June 7, 2021
    Publication date: April 28, 2022
    Inventors: Stephen I. Bandak, Kevin J. Black, Meghan C. Campbell
  • A2A Antagonists as Cognition and Motor Function Enhancers
    Publication number: 20130317019
    Abstract: Methods are described for inducing cognition and motor function enhancement in patients suffering from Parkinson's disease by administering an effective amount of an Adenosine 2a antagonist.
    Type: Application
    Filed: November 4, 2011
    Publication date: November 28, 2013
    Applicant: BIOTIE THERAPIES, INC.
    Inventors: Stephen I. Bandak, Kevin J. Black, Meghan C. Campbell